SV
Srdan Verstovsek
Medical Oncology
Credentials: ·
History
- 2001–2003
Medical Oncology
- 1998–2001
Internal Medicine
- 1988–1992
Medical School
Research
Review · Leukemia · 2022 · 3,530 citations
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis
New England Journal of Medicine · 2012 · First of 24 authors · Corresponding · 1,753 citations
Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis
New England Journal of Medicine · 2010 · First of 13 authors · Corresponding · 987 citations
315 papers
221 papers
141 papers
- SO
110 papers
98 papers
- FG
94 papers
- ZE
89 papers
86 papers · 9 as a fellow
